Artificial intelligence for human age-reversal
Insilico Medicine develops the advanced artificial intelligence algorithms to study the ageing processes and discover new interventions in ageing...
List view / Grid view
News
FDA approves new targeted treatment for acute myeloid leukemia
The U.S. Food and Drug Administration has granted the approval of Idhifa to Celgene Corporation and RealTime IDH2 Assay to Abbott Laboratories...
AdvantaPure® announces its ISO 9001:2015 Certification
Validates the Company’s Quality Management System...
New imaging technique allows early assessment of aortic aneurysm
Researchers have developed a new imaging technique which allows early assessment of aortic aneurysm which could potentially be used to assess a patient's rupture risk for abdominal aortic aneurysm...
New drug may slow progression of Parkinson’s disease
A preclinical model of Parkinson's disease was employed to compare the effects of the dopamine agonist ropinirole to a new drug...
Rainin’s calibration service helps ensure accurate, precise pipetting
Scientists at Novartis in Jersey, USA, rely on METTLER TOLEDO Rainin’s calibration and maintenance service to guarantee the correct operation of their pipettes...
FDA grants Breakthrough Therapy Designation status for acalabrutinib
It has been announced that the FDA has awarded AstraZeneca’s acalabrutinib product for MCL treatment Breakthrough Therapy Designation...
PEG-IONCs show potential as next-generation MRI contrast agents
A research team formed have tested a new non-toxic contrast agent for magnetic resonance imaging (MRI) and magnetic resonance angiography (MRA) that could be superior to the current dye, gadolinium.
Consortium established to support ICH M7 compliance
An industry work-group comprising of toxicologists, pharmaceutical companies and data experts plans to unveil the early results of a data sharing project...
Imfinzi wins breakthrough therapy designation
AstraZeneca and MedImmune, have today announced that the US Food and Drug Administration has granted breakthrough therapy designation for Imfinzi for the treatment of patients with locally-advanced, unresectable non-small cell lung cancer...
UK Biobank releases genetic data on 0.5m people
Genetic data on half a million people was made available for research last week by the UK Biobank study. Information about participants’ health and well-being, key body measurements, their diet, occupational history, mental health and activity levels are also included...
The return of the FT Global Pharmaceutical and Biotechnology Conference
The FT Global Pharmaceutical and Biotechnology Conference, now in its 35th successful year, will be returning to London this November...
BIOCAD does its sums for growth
Russian biotech company BIOCAD plans to leverage competitive advantages to take 5% of the European medicines market
FDA launches Supply Chain Security Toolkit for Medical Products
The U.S Food and Drugs Administration (FDA) has led a collaboration to create a Supply Chain Security Toolkit for Medical Products to maximise the available global resources and to deliver quality training and best practices for medical products...
Puration announces strategy to become cannabis market leader
Puration plans to displace pharmaceutical market leader, GW Pharmaceuticals, as part of strategy to grow US cannabis market
